Development of the Synthetic Route to PF-06878031 Part 1: Selective Alkylation Route

Author:

Brea Oriana1,Buck Julia1,Carson Nessa1ORCID,Derrick Andrew M.1,Fussell Steven J.1,Gymer Adam E. S.1,Hawksworth Michael1,Hopkins Adam W.1,Ingram Heather1,Johnson Rebecca A.1,Laity Daniel A.1,Mathew Jinu S.1,Moses Ian B.1,Rellegue James1,Rose Emily K.1,Twiddle Steven J. R.1ORCID,West Adam1

Affiliation:

1. Chemical Research and Development, Pfizer R&D UK Ltd., Sandwich, Kent CT13 9NJ, U.K.

Publisher

American Chemical Society (ACS)

Reference9 articles.

1. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends

2. Incretin therapies: highlighting common features and differences in the modes of action of glucagon‐like peptide‐1 receptor agonists and dipeptidyl peptidase‐4 inhibitors

3. Novo Nordisk A/S. WEGOVY (semaglutide) prescribing information. https://www.novo-pi.com/wegovy.pdf (accessed 2022-12-18).

4. Novo Nordisk A/S. SAXENDA (liraglutide) prescribing information. https://www.novo-pi.com/saxenda.pdf (accessed 2022-12-18).

5. Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Development of the Synthetic Route to PF-06878031 Part 2: Amide Reduction Route;Organic Process Research & Development;2024-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3